These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 20494761

  • 1. Effect of intravitreal triamcinolone acetonide injection on central macular thickness in diabetic patients having phacoemulsification.
    Ahmadabadi HF, Mohammadi M, Beheshtnejad H, Mirshahi A.
    J Cataract Refract Surg; 2010 Jun; 36(6):917-22. PubMed ID: 20494761
    [Abstract] [Full Text] [Related]

  • 2. Effect of a single intraoperative sub-Tenon injection of triamcinolone acetonide on the progression of diabetic retinopathy and visual outcomes after cataract surgery.
    Kim SY, Yang J, Lee YC, Park YH.
    J Cataract Refract Surg; 2008 May; 34(5):823-6. PubMed ID: 18471640
    [Abstract] [Full Text] [Related]

  • 3. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
    Cardillo JA, Melo LA, Costa RA, Skaf M, Belfort R, Souza-Filho AA, Farah ME, Kuppermann BD.
    Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
    [Abstract] [Full Text] [Related]

  • 4. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract.
    Dada T, Dhawan M, Garg S, Nair S, Mandal S.
    J Cataract Refract Surg; 2007 Sep; 33(9):1613-8. PubMed ID: 17720079
    [Abstract] [Full Text] [Related]

  • 5. Phacoemulsification with intravitreal bevacizumab and triamcinolone acetonide injection in diabetic patients with clinically significant macular edema and cataract.
    Akinci A, Muftuoglu O, Altınsoy A, Ozkılıc E.
    Retina; 2011 Apr; 31(4):755-8. PubMed ID: 21124251
    [Abstract] [Full Text] [Related]

  • 6. Prospective evaluation of intravitreal triamcinolone acetonide injection in macular edema associated with retinal vascular disorders.
    Tewari HK, Sony P, Chawla R, Garg SP, Venkatesh P.
    Eur J Ophthalmol; 2005 Apr; 15(5):619-26. PubMed ID: 16167293
    [Abstract] [Full Text] [Related]

  • 7. Randomized controlled European multicenter trial on the prevention of cystoid macular edema after cataract surgery in diabetics: ESCRS PREMED Study Report 2.
    Wielders LHP, Schouten JSAG, Winkens B, van den Biggelaar FJHM, Veldhuizen CA, Murta JCN, Goslings WRO, Kohnen T, Tassignon MJ, Joosse MV, Henry YP, Nagy ZZ, Rulo AHF, Findl O, Amon M, Nuijts RMMA, ESCRS PREMED study groupFrom University Eye Clinic Maastricht UMC+, Maastricht University Medical Center+ (Wielders, Schouten, van den Biggelaar, Veldhuizen, Nuijts), Maastricht, Maastricht University, Care and Public Health Research Institute, Department of Methodology and Statistics (Winkens), Maastricht, Zuyderland Medical Center, Department of Ophthalmology (Wielders, Schouten, Nuijts), Heerlen; Elisabeth-TweeSteden Hospital, Department of Ophthalmology (Goslings), Tilburg, Haaglanden Medical Center, Department of Ophthalmology (Joosse), The Hague, VU University Medical Center, Department of Ophthalmology (Henry), Amsterdam, and Eye Hospital Zonnestraal (Rulo), Hilversum, the Netherlands; Centro Hospitalar Universitário Coimbra and Association for Innovation and Biomedical Research on Light (Murta), Coimbra, Portugal; Goethe University, Department of Ophthalmology (Kohnen); Frankfurt am Main, Germany Antwerp University Hospital and University of Antwerp, Department of Ophthalmology (Tassignon), Antwerp, Belgium Semmelweis University, Department of Ophthalmology (Nagy), Budapest, Hungary Vienna Institute for Research in Ocular Surgery, Hanusch Hospital (Findl), and Hospital of the Brothers of St. John of God, Department of Ophthalmology (Amon), Vienna, Austria..
    J Cataract Refract Surg; 2018 Jul; 44(7):836-847. PubMed ID: 30055692
    [Abstract] [Full Text] [Related]

  • 8. Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema.
    Batioğlu F, Ozmert E, Parmak N, Celik S.
    Int Ophthalmol; 2007 Oct; 27(5):299-306. PubMed ID: 17453151
    [Abstract] [Full Text] [Related]

  • 9. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial.
    Massin P, Audren F, Haouchine B, Erginay A, Bergmann JF, Benosman R, Caulin C, Gaudric A.
    Ophthalmology; 2004 Feb; 111(2):218-24; discussion 224-5. PubMed ID: 15019365
    [Abstract] [Full Text] [Related]

  • 10. [Triamcinolone in the treatment of the diabetic macular edema--one-year results].
    Dusová J, Studnicka J, Rencová E, Korda V, Hejcmanová D.
    Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654
    [Abstract] [Full Text] [Related]

  • 11. Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial.
    Audren F, Erginay A, Haouchine B, Benosman R, Conrath J, Bergmann JF, Gaudric A, Massin P.
    Acta Ophthalmol Scand; 2006 Oct; 84(5):624-30. PubMed ID: 16965492
    [Abstract] [Full Text] [Related]

  • 12. Comparing intravitreal triamcinolone acetonide and bevacizumab injections for the treatment of diabetic macular oedema: a randomized double-blind study.
    Isaac DL, Abud MB, Frantz KA, Rassi AR, Avila M.
    Acta Ophthalmol; 2012 Feb; 90(1):56-60. PubMed ID: 20015098
    [Abstract] [Full Text] [Related]

  • 13. Combined phacoemulsification surgery and intravitreal triamcinolone injection versus stand-alone surgery in patients with type 2 diabetes: a prospective randomized trial.
    Zaher Addeen S, Shaddoud I.
    BMC Ophthalmol; 2022 Nov 19; 22(1):445. PubMed ID: 36401233
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of intravitreal triamcinolone acetonide in long standing diabetic macular edema: a microperimetry and optical coherence tomography study.
    Grenga P, Lupo S, Domanico D, Vingolo EM.
    Retina; 2008 Oct 19; 28(9):1270-5. PubMed ID: 18664938
    [Abstract] [Full Text] [Related]

  • 15. Intravitreal triamcinolone acetonide as primary treatment for diffuse diabetic macular edema: a prospective noncomparative interventional case series.
    Nicolò M, Nasciuti F, Lai S, Ghiglione D, Borgia L, Calabria G.
    Eur J Ophthalmol; 2006 Oct 19; 16(1):129-33. PubMed ID: 16496256
    [Abstract] [Full Text] [Related]

  • 16. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X, Li J, Hu X, Yu S, Pan J, Tang S.
    Retina; 2011 May 19; 31(5):838-45. PubMed ID: 21293319
    [Abstract] [Full Text] [Related]

  • 17. Intravitreal triamcinolone acetonide for diffuse diabetic macular edema: phase 2 trial comparing 4 mg vs 2 mg.
    Audren F, Lecleire-Collet A, Erginay A, Haouchine B, Benosman R, Bergmann JF, Gaudric A, Massin P.
    Am J Ophthalmol; 2006 Nov 19; 142(5):794-99. PubMed ID: 16978576
    [Abstract] [Full Text] [Related]

  • 18. Macular function by multifocal electroretinogram in diabetic macular edema after intravitreal triamcinolone acetonide injection.
    Karacorlu M, Ozdemir H, Senturk F, Arf Karacorlu S, Uysal O.
    Eur J Ophthalmol; 2008 Nov 19; 18(4):601-8. PubMed ID: 18609482
    [Abstract] [Full Text] [Related]

  • 19. Early change of central macular thickness after intravitreous triamcinolone or bevacizumab in diabetic macular edema or retinal vein occlusion.
    Sonoda Y, Arimura N, Shimura M, Sakamoto T.
    Retina; 2011 Feb 19; 31(2):290-7. PubMed ID: 21102366
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.